Abbott to promote Crestor

pharmafile | August 28, 2008 | News story | Sales and Marketing |  Crestor 

Related Content

shutterstock_138095450

Grünenthal buys European rights to AstraZeneca’s Crestor for a potential $350m

Grünenthal has picked up AstraZeneca’s statin therapy Crestor (rosuvastatin), currently approved in dyslipidaemia and hypercholesterolaemia …

astrazeneca_crestor_rosuvastatin_40mg

AstraZeneca loses legal bid to block Crestor generics

A US district court judge has refused AstraZeneca’s request for a temporary restraining order blocking …

astrazeneca_sign_sky

AstraZeneca files suit to block FDA from approving copies of cholesterol drug Crestor

Anglo-Swedish drug firm AstraZeneca (LSE: AZN) has filed a temporary restraining order to prevent the US …

The Gateway to Local Adoption Series

Latest content